Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 010012
Company: LILLY
Company: LILLY
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SANDRIL | RESERPINE | 2.5MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
07/20/1983 | SUPPL-6 | Labeling |
Label is not available on this site. |
||
10/22/1981 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |